67
Participants
Start Date
March 31, 2010
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2010
Placebo
Matching placebo in capsules administered as a single oral dose.
250 mg CK-2017357
250 mg CK-2017357 in capsules administered as a single oral dose.
500 mg CK-2017357
500 mg CK-2017357 in capsules administered as a single oral dose.
SUNY Upstate Medical Center, Syracuse
Penn State, University Park
Drexel University College of Medicine, Dept of Neurology, Philadelphia
Johns Hopkins Hospital, Baltimore
Duke University, Durham
Mayo Clinic Florida, Jacksonville
University of Kentucky, Lexington
Washington University, St Louis
The University of Texas Health Science Center at San Antonio, San Antonio
Phoenix Neurological Associates, Ltd., Phoenix
University Neurology Associates, Fresno
California Pacific Medical Center, San Francisco
Providence ALS Center, Portland
Massachusetts General Hospital, Boston
University of Vermont, Burlington
Lead Sponsor
Cytokinetics
INDUSTRY